Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Texas Instruments Inc ha un obiettivo di prezzo consensuale di $202.03, basato sulle valutazioni degli ultimi 31 analisti. Il massimo è $298 emesso da Evercore ISI Group il ottobre 23, 2024, mentre il minimo è $125 emesso da Barclays il aprile 22, 2025. Le ultime 3 valutazioni degli analisti sono state pubblicate da JP Morgan, TD Cowen e Cantor Fitzgerald il ottobre 22, 2025. Con un obiettivo di prezzo medio di $193.33 tra JP Morgan, TD Cowen e Cantor Fitzgerald, c'è un cambiamento implicito del 14.20% upside per Texas Instruments Inc secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/22/2025 | 24.05% | JP Morgan | $225 → $210 | Maintains | Overweight | |||
10/22/2025 | 18.14% | TD Cowen | $210 → $200 | Maintains | Buy | |||
10/22/2025 | 0.42% | Cantor Fitzgerald | $200 → $170 | Maintains | Neutral | |||
10/22/2025 | 3.37% | Truist Securities | $196 → $175 | Maintains | Hold | |||
10/22/2025 | 18.14% | Rosenblatt | $245 → $200 | Maintains | Buy | |||
10/22/2025 | 0.42% | Wells Fargo | $195 → $170 | Maintains | Equal-Weight | |||
10/22/2025 | 18.14% | Susquehanna | $240 → $200 | Maintains | Positive | |||
10/22/2025 | 0.42% | Stifel | $185 → $170 | Maintains | Hold | |||
10/22/2025 | 18.14% | Goldman Sachs | $230 → $200 | Maintains | Buy | |||
10/20/2025 | -11.39% | Mizuho | $200 → $150 | Downgrade | Neutral → Underperform | |||
10/17/2025 | 9.28% | Stifel | $192 → $185 | Maintains | Hold | |||
10/16/2025 | 38.82% | Citigroup | $260 → $235 | Maintains | Buy | |||
10/13/2025 | 12.23% | B of A Securities | $208 → $190 | Downgrade | Neutral → Underperform | |||
09/12/2025 | 13.41% | Morgan Stanley | $197 → $192 | Maintains | Underweight | |||
09/08/2025 | 29.95% | Benchmark | $220 → $220 | Reiterates | Buy → Buy | |||
09/05/2025 | 22.87% | B of A Securities | $218 → $208 | Maintains | Neutral | |||
07/28/2025 | 35.86% | Wolfe Research | → $230 | Upgrade | Peer Perform → Outperform | |||
07/23/2025 | 18.14% | Mizuho | $205 → $200 | Maintains | Neutral | |||
07/23/2025 | 32.91% | JP Morgan | $195 → $225 | Maintains | Overweight | |||
07/23/2025 | 15.78% | Truist Securities | $171 → $196 | Maintains | Hold | |||
07/23/2025 | 15.19% | Wells Fargo | $215 → $195 | Maintains | Equal-Weight | |||
07/23/2025 | 41.77% | Susquehanna | $250 → $240 | Maintains | Positive | |||
07/23/2025 | 29.95% | Baird | $175 → $220 | Maintains | Outperform | |||
07/23/2025 | 44.72% | Rosenblatt | $245 → $245 | Maintains | Buy | |||
07/23/2025 | 29.95% | Benchmark | $200 → $220 | Maintains | Buy | |||
07/22/2025 | 47.68% | Susquehanna | $220 → $250 | Maintains | Positive | |||
07/21/2025 | — | Seaport Global | — | Upgrade | Sell → Neutral | |||
07/18/2025 | 13.41% | Stifel | $160 → $192 | Maintains | Hold | |||
07/16/2025 | 27% | Wells Fargo | $190 → $215 | Maintains | Equal-Weight | |||
07/14/2025 | 50.63% | UBS | $245 → $255 | Maintains | Buy | |||
07/11/2025 | 44.72% | TD Cowen | $200 → $245 | Upgrade | Hold → Buy | |||
07/10/2025 | 32.91% | Goldman Sachs | → $225 | Initiates | → Buy | |||
07/08/2025 | 41.77% | Keybanc | $215 → $240 | Maintains | Overweight | |||
07/08/2025 | 21.09% | Mizuho | $170 → $205 | Maintains | Neutral | |||
07/07/2025 | 53.58% | Citigroup | $220 → $260 | Maintains | Buy | |||
07/07/2025 | 44.72% | UBS | $215 → $245 | Maintains | Buy | |||
06/25/2025 | 18.14% | TD Cowen | $160 → $200 | Maintains | Hold | |||
06/18/2025 | 18.14% | Cantor Fitzgerald | $170 → $200 | Maintains | Neutral | |||
06/16/2025 | 12.23% | Wells Fargo | $175 → $190 | Maintains | Equal-Weight | |||
06/09/2025 | 29.95% | Citigroup | $210 → $220 | Maintains | Buy | |||
04/30/2025 | -23.21% | Seaport Global | → $130 | Initiates | → Sell | |||
04/24/2025 | 0.42% | Mizuho | $190 → $170 | Maintains | Neutral | |||
04/24/2025 | 18.14% | Benchmark | $230 → $200 | Maintains | Buy | |||
04/24/2025 | 27% | UBS | $225 → $215 | Maintains | Buy | |||
04/24/2025 | -12.58% | Morgan Stanley | $146 → $148 | Maintains | Underweight | |||
04/24/2025 | 0.42% | Cantor Fitzgerald | $200 → $170 | Maintains | Neutral | |||
04/24/2025 | 15.19% | JP Morgan | $230 → $195 | Maintains | Overweight | |||
04/24/2025 | 1.01% | Truist Securities | $195 → $171 | Maintains | Hold | |||
04/24/2025 | -5.49% | TD Securities | $160 → $160 | Reiterates | Hold → Hold | |||
04/24/2025 | 27% | Keybanc | $250 → $215 | Maintains | Overweight | |||
04/24/2025 | 3.37% | Wells Fargo | $200 → $175 | Maintains | Equal-Weight | |||
04/24/2025 | 27.59% | Rosenblatt | $216 → $216 | Maintains | Buy | |||
04/22/2025 | -26.16% | Barclays | $180 → $125 | Downgrade | Equal-Weight → Underweight | |||
04/17/2025 | -5.49% | Stifel | $200 → $160 | Maintains | Hold | |||
04/16/2025 | 3.96% | B of A Securities | $220 → $176 | Maintains | Neutral | |||
04/14/2025 | 32.91% | UBS | $250 → $225 | Maintains | Buy | |||
04/11/2025 | 24.05% | Citigroup | $235 → $210 | Maintains | Buy | |||
04/07/2025 | 3.37% | Baird | $175 → $175 | Upgrade | Neutral → Outperform | |||
01/24/2025 | -2.53% | Morgan Stanley | $167 → $165 | Maintains | Underweight | |||
01/24/2025 | 15.19% | Truist Securities | $199 → $195 | Maintains | Hold | |||
01/24/2025 | 12.23% | Mizuho | $200 → $190 | Maintains | Neutral | |||
01/24/2025 | 6.33% | Barclays | $200 → $180 | Maintains | Equal-Weight | |||
01/24/2025 | 18.14% | Cantor Fitzgerald | $200 → $200 | Reiterates | Neutral → Neutral | |||
01/24/2025 | 35.86% | Benchmark | $230 → $230 | Reiterates | Buy → Buy | |||
01/21/2025 | 47.68% | Rosenblatt | $250 → $250 | Maintains | Buy | |||
01/17/2025 | 18.14% | Wells Fargo | $208 → $200 | Maintains | Equal-Weight | |||
01/13/2025 | 22.87% | Wells Fargo | $215 → $208 | Maintains | Equal-Weight | |||
11/22/2024 | 27% | Wells Fargo | → $215 | Initiates | → Equal-Weight | |||
10/23/2024 | 27% | B of A Securities | $220 → $215 | Maintains | Neutral | |||
10/23/2024 | 12.23% | Truist Securities | $198 → $190 | Maintains | Hold | |||
10/23/2024 | 18.14% | Cantor Fitzgerald | $200 → $200 | Reiterates | Neutral → Neutral | |||
10/23/2024 | 18.14% | Barclays | $210 → $200 | Maintains | Equal-Weight | |||
10/23/2024 | 76.03% | Evercore ISI Group | $268 → $298 | Maintains | Outperform | |||
10/23/2024 | -1.35% | Morgan Stanley | $154 → $167 | Maintains | Underweight | |||
10/23/2024 | 3.37% | Baird | $200 → $175 | Maintains | Neutral | |||
10/23/2024 | 47.68% | Rosenblatt | $250 → $250 | Maintains | Buy | |||
10/23/2024 | 35.86% | Benchmark | $230 → $230 | Reiterates | Buy → Buy | |||
10/21/2024 | 41.77% | Susquehanna | $250 → $240 | Maintains | Positive | |||
10/14/2024 | 47.68% | Rosenblatt | $250 → $250 | Maintains | Buy | |||
10/08/2024 | 18.14% | Cantor Fitzgerald | $210 → $200 | Maintains | Neutral | |||
08/21/2024 | 18.14% | Deutsche Bank | $185 → $200 | Maintains | Hold | |||
08/21/2024 | 16.96% | Truist Securities | $203 → $198 | Maintains | Hold | |||
08/21/2024 | 24.05% | Cantor Fitzgerald | $210 → $210 | Reiterates | Neutral → Neutral | |||
08/21/2024 | 38.82% | Citigroup | $200 → $235 | Upgrade | Neutral → Buy | |||
08/20/2024 | 58.31% | Evercore ISI Group | $255 → $268 | Maintains | Outperform | |||
07/24/2024 | 12.23% | Mizuho | $170 → $190 | Maintains | Neutral | |||
07/24/2024 | 47.68% | Keybanc | $200 → $250 | Maintains | Overweight | |||
07/24/2024 | 24.05% | Cantor Fitzgerald | $210 → $210 | Reiterates | Neutral → Neutral | |||
07/24/2024 | 18.14% | Baird | $175 → $200 | Maintains | Neutral | |||
07/24/2024 | 9.28% | Deutsche Bank | $160 → $185 | Maintains | Hold | |||
07/24/2024 | 24.05% | Barclays | $190 → $210 | Maintains | Equal-Weight | |||
07/24/2024 | 19.91% | Truist Securities | $167 → $203 | Maintains | Hold | |||
07/24/2024 | 35.86% | Benchmark | $230 → $230 | Reiterates | Buy → Buy | |||
07/24/2024 | 35.86% | JP Morgan | $195 → $230 | Maintains | Overweight | |||
07/24/2024 | 3.96% | Goldman Sachs | $157 → $176 | Maintains | Sell | |||
07/24/2024 | 9.28% | Jefferies | $175 → $185 | Maintains | Hold | |||
07/24/2024 | 47.68% | Rosenblatt | $250 → $250 | Maintains | Buy | |||
07/22/2024 | 47.68% | Rosenblatt | $210 → $250 | Maintains | Buy | |||
07/18/2024 | 18.14% | Stifel | $172 → $200 | Maintains | Hold | |||
07/17/2024 | 47.68% | Susquehanna | $205 → $250 | Maintains | Positive |
L'ultimo obiettivo di prezzo per Texas Instruments (NASDAQ:TXN) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $210.00 prevedendo che TXN raggiunga rise entro 12 mesi (un possibile 24.05% upside).
L'ultima valutazione degli analisti per Texas Instruments (NASDAQ:TXN) è stato fornita da JP Morgan e Texas Instruments mantenuto il suo rating overweight.
L'ultima revisione al rialzo di Texas Instruments Inc è avvenuta il luglio 28, 2025, quando Wolfe Research ha alzato il suo obiettivo di prezzo a $230. In precedenza Wolfe Research aveva a peer perform per Texas Instruments Inc.
L'ultima revisione al ribasso di Texas Instruments Inc si è verificata il ottobre 20, 2025, quando Mizuho ha modificato il suo obiettivo di prezzo da $200 a $150 per Texas Instruments Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Texas Instruments e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Texas Instruments è stata depositata il ottobre 22, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a ottobre 22, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Texas Instruments (TXN) è stata una mantenuto con un obiettivo di prezzo di $225.00 a $210.00. Il prezzo attuale a cui Texas Instruments (TXN) è scambiato è $169.29, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.